Table 3.
Apical Hypokinesis | Nonapical Hypokinesis | Global Hypokinesis | |
---|---|---|---|
Patients | 7 | 12 | 6 |
Age, Mean (SD) | 74.6 (9.3) | 52.3 (14.9) | 53.5 (8.9) |
Female Gender | 7/7 (100%) | 8/12 (67%) | 5/6 (83%) |
Medical History: | |||
Hypertension | 3/7 (43%) | 3/12 (25%) | 0/6 (0%) |
Hyperlipidemia | 0/7 (0) | 1/12 (8%) | 1/6 (17%) |
Diabetes | 1/7 (14%) | 0/12 (0%) | 0/6 (0%) |
CAD | 2/7 (29%) | 0/12 (0%) | 1/6 (17%) |
Medications: | |||
Statin | 1/7 (14%) | 1/12 (8%) | 1/6 (17%) |
Beta-Blocker | 3/7 (43%) | 0/12 (0%) | 1/6 (17%) |
ACE-Inhibitor | 0/7 (0%) | 1/12 (8%) | 0/6 (0%) |
Aspirin | 1/7 (14%) | 0/12 (0%) | 0/6 (0%) |
Current Smoker | 1/7 (14%) | 5/12 (42%) | 4/6 (67%) |
Hunt-Hess 4–5 | 4/7 (57%) | 10/12 (83%) | 4/6 (67%) |
Thick SAH | 7/7 (100%) | 11/12 (92%) | 5/6 (83%) |
EKG Changes: | |||
QT Prolonged | 0/7 (0%) | 3/12 (25%) | 0/6 (0%) |
T-wave changes | 5/7 (71%) | 5/12 (42%) | 2/6 (33%) |
SD, standard deviation; CAD, coronary artery disease; Thick SAH, Fisher grade 3 subarachnoid hemorrhage; ICA, internal carotid artery; ACA, anterior cerebral artery; MCA, middle cerebral artery.